• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个新的 POU1F1 基因的隐性剪接突变导致联合垂体激素缺乏。

A novel recessive splicing mutation in the POU1F1 gene causing combined pituitary hormone deficiency.

机构信息

Laboratory of Human Genetics, Department of Medical Sciences, Eastern Piedmont University and Interdisciplinary Research Center on Autoimmune Diseases, 28100 Novara, Italy.

出版信息

J Endocrinol Invest. 2009 Sep;32(8):653-8. doi: 10.1007/BF03345736. Epub 2009 May 12.

DOI:10.1007/BF03345736
PMID:19498317
Abstract

BACKGROUND

Mutations in the gene encoding the pituitary transcription factor POU1F1 (Pit-1, pituitary transcription factor-1) have been described in combined pituitary hormone deficiency (CPHD).

AIM

The aim of this study was the characterisation of the molecular defect causing CPHD in a patient born to consanguineous parents.

SUBJECT AND METHODS

The case of a 12.5-yr-old girl presenting with severe growth failure at diagnosis (-3 SD score at 3 months) and deficiency of GH, PRL, and TSH was investigated for the presence of POU1F1 gene mutations by denaturing high performance liquid chromatography analysis.

RESULTS

A novel mutation adjacent to the IVS2 splicing acceptor site (IVS2-3insA) was identified in the patient at the homozygous state. Analysis of patient's lymphocyte mRNA and an in vitro splicing assay revealed the presence of 2 aberrant splicing products: a) deletion of the first 71 nucleotides of exon 3, altering the open reading frame and generating a premature stop codon, b) total exon 3 skipping resulting in an in frame deleted mRNA encoding a putative protein lacking part of the transactivation domain and of the POUspecific homeodomain. Notably, the patient's relatives heterozygous for the mutation had PRL levels under the normal range with no evident clinical symptoms.

CONCLUSIONS

The IVS2- 3insAmutation, responsible for CPHD at the homozygous state, causes the presence of 2 aberrant splicing products encoding non-functional products. In the heterozygotes one normal allele might not guarantee a complete pituitary function.

摘要

背景

编码垂体转录因子 POU1F1(Pit-1,垂体转录因子-1)的基因突变已在联合垂体激素缺乏症(CPHD)中描述。

目的

本研究的目的是描述在一对近亲父母所生的患有 CPHD 的患者中导致 CPHD 的分子缺陷。

对象和方法

对一名 12.5 岁女孩进行了研究,该女孩在诊断时(3 个月时的-3SD 评分)存在严重的生长发育迟缓,且缺乏 GH、PRL 和 TSH,通过变性高效液相色谱分析检测 POU1F1 基因突变。

结果

在患者的纯合状态下发现了一个紧邻 IVS2 剪接受体位点的新突变(IVS2-3insA)。对患者淋巴细胞 mRNA 的分析和体外剪接试验表明存在 2 种异常剪接产物:a)缺失外显子 3 的前 71 个核苷酸,改变开放阅读框并产生过早终止密码子,b)外显子 3 完全跳过,导致编码推定蛋白的无义 mRNA,该蛋白缺乏部分反式激活域和 POUspecific 同源结构域。值得注意的是,突变的杂合亲属的 PRL 水平处于正常范围,没有明显的临床症状。

结论

导致纯合状态下 CPHD 的 IVS2-3insA 突变导致存在 2 种异常剪接产物,编码无功能产物。在杂合子中,一个正常的等位基因可能不能保证完全的垂体功能。

相似文献

1
A novel recessive splicing mutation in the POU1F1 gene causing combined pituitary hormone deficiency.一个新的 POU1F1 基因的隐性剪接突变导致联合垂体激素缺乏。
J Endocrinol Invest. 2009 Sep;32(8):653-8. doi: 10.1007/BF03345736. Epub 2009 May 12.
2
Two novel mutations in the POU1F1 gene generate null alleles through different mechanisms leading to combined pituitary hormone deficiency.两个新的 POU1F1 基因突变通过不同机制产生无效等位基因,导致联合垂体激素缺乏症。
Clin Endocrinol (Oxf). 2012 Mar;76(3):387-93. doi: 10.1111/j.1365-2265.2011.04236.x.
3
A novel germline mutation, IVS4+1G>A, of the POU1F1 gene underlying combined pituitary hormone deficiency.一种导致联合垂体激素缺乏的POU1F1基因的新型种系突变,IVS4+1G>A。
Horm Res. 2008;69(1):60-4. doi: 10.1159/000111797. Epub 2007 Dec 4.
4
A mutation of the β-domain in POU1F1 causes pituitary deficiency due to dominant PIT-1β expression.POU1F1 的β-结构域突变导致由于显性 PIT-1β 表达引起的垂体功能减退。
Eur J Endocrinol. 2021 May 21;185(1):1-12. doi: 10.1530/EJE-20-1313.
5
New N-terminal located mutation (Q4ter) within the POU1F1-gene (PIT-1) causes recessive combined pituitary hormone deficiency and variable phenotype.POU1F1基因(PIT-1)内新发现的位于N端的突变(Q4ter)导致隐性遗传性联合垂体激素缺乏及可变表型。
Growth Horm IGF Res. 2003 Oct;13(5):264-8. doi: 10.1016/s1096-6374(03)00015-7.
6
Identification of a novel mutation in the exon 2 splice donor site of the POU1F1/PIT-1 gene in Japanese identical twins with mild combined pituitary hormone deficiency.在患有轻度联合垂体激素缺乏症的日本同卵双胞胎中,鉴定出 POU1F1/PIT-1 基因外显子 2 剪接受体位点的一个新突变。
Clin Endocrinol (Oxf). 2012 Jan;76(1):78-87. doi: 10.1111/j.1365-2265.2011.04165.x.
7
Combined pituitary hormone deficiency in Australian children: clinical and genetic correlates.澳大利亚儿童的联合垂体激素缺乏症:临床与遗传学关联
Clin Endocrinol (Oxf). 2003 Jun;58(6):785-94. doi: 10.1046/j.1365-2265.2003.01781.x.
8
Identification and functional analysis of the novel S179R POU1F1 mutation associated with combined pituitary hormone deficiency.与垂体激素联合缺乏相关的新型S179R POU1F1突变的鉴定及功能分析
J Clin Endocrinol Metab. 2006 Dec;91(12):4981-7. doi: 10.1210/jc.2005-2289. Epub 2006 Sep 12.
9
PROP1, HESX1, POU1F1, LHX3 and LHX4 mutation and deletion screening and GH1 P89L and IVS3+1/+2 mutation screening in a Dutch nationwide cohort of patients with combined pituitary hormone deficiency.对一个荷兰全国性的联合垂体激素缺乏症患者队列进行PROP1、HESX1、POU1F1、LHX3 和 LHX4 突变和缺失筛查,以及 GH1 P89L 和 IVS3+1/+2 突变筛查。
Horm Res Paediatr. 2010;73(5):363-71. doi: 10.1159/000308169. Epub 2010 Apr 14.
10
A novel POU1F1 mutation (p.Thr168IlefsX7) associated with an early and severe form of combined pituitary hormone deficiency: functional analysis and follow-up from infancy to adulthood.一种新型的 POUSF1 突变(p.Thr168IlefsX7)与一种早期和严重的联合垂体激素缺乏症有关:从婴儿期到成年期的功能分析和随访。
Clin Endocrinol (Oxf). 2011 Aug;75(2):214-9. doi: 10.1111/j.1365-2265.2011.04028.x.

引用本文的文献

1
A Novel Splice-Site Deletion in the Gene Causes Combined Pituitary Hormone Deficiency in Multiple Sudanese Pedigrees.一个新的剪接位点缺失导致多个苏丹家系的联合垂体激素缺乏症。
Genes (Basel). 2022 Apr 8;13(4):657. doi: 10.3390/genes13040657.
2
Extreme Short Stature and Severe Neurological Impairment in a 17-Year-Old Male With Untreated Combined Pituitary Hormone Deficiency Due to Mutation.一名17岁男性因突变导致未经治疗的联合垂体激素缺乏症,出现极端矮小身材和严重神经功能障碍。
Front Endocrinol (Lausanne). 2019 Jun 27;10:381. doi: 10.3389/fendo.2019.00381. eCollection 2019.
3
Pathogenesis analysis of pituitary adenoma based on gene expression profiling.

本文引用的文献

1
Messenger RNA regulation: to translate or to degrade.信使核糖核酸调控:翻译还是降解
EMBO J. 2008 Feb 6;27(3):471-81. doi: 10.1038/sj.emboj.7601977.
2
A novel germline mutation, IVS4+1G>A, of the POU1F1 gene underlying combined pituitary hormone deficiency.一种导致联合垂体激素缺乏的POU1F1基因的新型种系突变,IVS4+1G>A。
Horm Res. 2008;69(1):60-4. doi: 10.1159/000111797. Epub 2007 Dec 4.
3
A case of prolactin deficiency with familial puerperal alactogenesis accompanying impaired ACTH secretion.一例伴有促肾上腺皮质激素分泌受损的家族性产后无乳症的催乳素缺乏病例。
基于基因表达谱的垂体腺瘤发病机制分析
Oncol Lett. 2014 Dec;8(6):2423-2430. doi: 10.3892/ol.2014.2613. Epub 2014 Oct 13.
Endocr J. 2007 Feb;54(1):59-62. doi: 10.1507/endocrj.k05-163. Epub 2006 Nov 8.
4
Dynamic interactions between Pit-1 and C/EBPalpha in the pituitary cell nucleus.垂体细胞核中Pit-1与C/EBPα之间的动态相互作用。
Mol Cell Biol. 2006 Nov;26(21):8087-98. doi: 10.1128/MCB.02410-05. Epub 2006 Aug 14.
5
Novel mutations within the POU1F1 gene associated with variable combined pituitary hormone deficiency.与可变型联合垂体激素缺乏症相关的POU1F1基因新突变。
J Clin Endocrinol Metab. 2005 Aug;90(8):4762-70. doi: 10.1210/jc.2005-0570. Epub 2005 May 31.
6
The pituitary-specific transcription factor, Pit-1, can direct changes in the chromatin structure of the prolactin promoter.垂体特异性转录因子Pit-1可指导催乳素启动子染色质结构的变化。
Mol Endocrinol. 2005 Jan;19(1):138-47. doi: 10.1210/me.2004-0016. Epub 2004 Sep 16.
7
The de novo Q167K mutation in the POU1F1 gene leads to combined pituitary hormone deficiency in an Italian patient.POU1F1基因中的新生Q167K突变导致一名意大利患者出现垂体激素联合缺乏症。
Pediatr Res. 2003 Nov;54(5):635-40. doi: 10.1203/01.PDR.0000084113.41375.1E. Epub 2003 Aug 6.
8
Combined pituitary hormone deficiency in Australian children: clinical and genetic correlates.澳大利亚儿童的联合垂体激素缺乏症:临床与遗传学关联
Clin Endocrinol (Oxf). 2003 Jun;58(6):785-94. doi: 10.1046/j.1365-2265.2003.01781.x.
9
A novel nonsense mutation in the Pit-1 gene: evidence for a gene dosage effect.垂体特异性转录因子1基因中的一种新型无义突变:基因剂量效应的证据。
J Clin Endocrinol Metab. 2003 Mar;88(3):1241-7. doi: 10.1210/jc.2002-021510.
10
Identification of single nucleotide variations in the coding and regulatory regions of the myelin-associated glycoprotein gene and study of their association with multiple sclerosis.髓鞘相关糖蛋白基因编码区和调控区单核苷酸变异的鉴定及其与多发性硬化症相关性的研究。
J Neuroimmunol. 2002 May;126(1-2):196-204. doi: 10.1016/s0165-5728(02)00061-9.